Showing papers by "Ik-Kyung Jang published in 1986"

TL;DR: In a double-blind, placebo-controlled, randomized trial the long-term effects of intravenous administration of recombinant tissue-type plasminogen activator versus placebo were compared in relation to left ventricular function, coronary patency rate and antigenicity in 28 patients with a first myocardial infarction.